Today is Sunday, Sep. 27, 2020

Department of Internal Medicine

Cardiovascular Health and Disease

Photo of  Charles Hattemer, MD

Charles Hattemer, MD

Chief, Division of Cardiovascular Health and Disease; Mabel Stonehill Endowed Professor of Medicine; Interventional Cardiology

Clinical Interest

Cardiology
Cardiology Interventional

Specialties

Cardiovascular Disease
Internal Medicine

Education/Credentials
  • Medical Degree: Case Western Reserve University School of Medicine
  • Internal Medicine Residency: University of Cincinnati College of Medicine
  • Cardiovascular Disease Fellowship: University of Cincinnati College of Medicine
Board Certifications & Licenses
  • American Board of Internal Medicine 09/13/1989
  • American Board of Internal Medicine (Cardiovascular Disease) 11/04/1993
Contact Information
  • Medical Science Building
  • 231 Albert Sabin Way, MLC 0542
  • Cincinnati, Ohio 45267
  • Office 513-558-2307
  • Email charles.hattemer@uc.edu
  • UC Institute Member Seal

Peer Reviewed Publications

Dippel, E J; Kereiakes, D J; Tramuta, D A; Broderick, T M; Shimshak, T M; Roth, E M; Hattemer, C R; Runyon, J P; Whang, D D; Schneider, J F; Abbottsmith, C W 2001. Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 52 3, 279-86

Kereiakes, D J; Obenchain, R L; Barber, B L; Smith, A; McDonald, M; Broderick, T M; Runyon, J P; Shimshak, T M; Schneider, J F; Hattemer, C R; Roth, E M; Whang, D D; Cocks, D; Abbottsmith, C W 2000. Abciximab provides cost-effective survival advantage in high-volume interventional practice. American heart journal, 140 4, 603-10

Kereiakes, D J; Broderick, T M; Roth, E M; Whang, D; Shimshak, T; Runyon, J P; Hattemer, C; Schneider, J; Lacock, P; Mueller, M; Abbottsmith, C W 1999. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. The American journal of cardiology, 84 4, 391-5

Ritchie, M E; Hattemer, C; Lenihan, D 1998. Ergonovine-testing-directed therapy and long-term outcome of sudden-death survivors with no apparent heart disease. Cardiology, 89 1, 76-8

Gibler, W B; Runyon, J P; Levy, R C; Sayre, M R; Kacich, R; Hattemer, C R; Hamilton, C; Gerlach, J W; Walsh, R A 1995. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Annals of emergency medicine, 25 1, 1-8

Yingling, K W; Hattemer, C; Rouan, G W; Luke, R G 1991. Internal medicine residents' monitoring of their colleagues' moonlighting activities at the University of Cincinnati. Academic medicine : journal of the Association of American Medical Colleges, 66 11, 705-6